These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 37492896

  • 1. Combined doxorubicin and arctigenin treatment induce cell cycle arrest-associated cell death by promoting doxorubicin uptake in doxorubicin-resistant breast cancer cells.
    Lee MG, Lee KS, Nam KS.
    IUBMB Life; 2023 Sep; 75(9):765-777. PubMed ID: 37492896
    [Abstract] [Full Text] [Related]

  • 2. Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells.
    Lee KS, Lee MG, Kwon YS, Nam KS.
    Int J Mol Sci; 2020 Apr 23; 21(8):. PubMed ID: 32340377
    [Abstract] [Full Text] [Related]

  • 3. Isorhamnetin induces cell cycle arrest and apoptosis by triggering DNA damage and regulating the AMPK/mTOR/p70S6K signaling pathway in doxorubicin-resistant breast cancer.
    Yang T, Xiao Y, Liu S, Luo F, Tang D, Yu Y, Xie Y.
    Phytomedicine; 2023 Jun 23; 114():154780. PubMed ID: 37004402
    [Abstract] [Full Text] [Related]

  • 4. Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.
    Xue C, Wang C, Sun Y, Meng Q, Liu Z, Huo X, Sun P, Sun H, Ma X, Ma X, Peng J, Liu K.
    Oncotarget; 2017 Jan 31; 8(5):8622-8632. PubMed ID: 28052008
    [Abstract] [Full Text] [Related]

  • 5. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL, Jiang QC, Wang SR.
    Breast Cancer; 2018 Mar 31; 25(2):233-242. PubMed ID: 29181822
    [Abstract] [Full Text] [Related]

  • 6. Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells.
    Tun JO, Salvador-Reyes LA, Velarde MC, Saito N, Suwanborirux K, Concepcion GP.
    Mar Drugs; 2019 Sep 16; 17(9):. PubMed ID: 31527453
    [Abstract] [Full Text] [Related]

  • 7. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH, Shin YJ, Won AJ, Lee BM, Choi WS, Jung JH, Chung HY, Kim HS.
    Biochim Biophys Acta; 2014 Jan 16; 1840(1):615-25. PubMed ID: 24161697
    [Abstract] [Full Text] [Related]

  • 8. Apigenin alleviates resistance to doxorubicin in breast cancer cells by acting on the JAK/STAT signaling pathway.
    Maashi MS, Al-Mualm M, Al-Awsi GRL, Opulencia MJC, Al-Gazally ME, Abdullaev B, Abdelbasset WK, Ansari MJ, Jalil AT, Alsaikhan F, Shalaby MN, Mustafa YF.
    Mol Biol Rep; 2022 Sep 16; 49(9):8777-8784. PubMed ID: 35804214
    [Abstract] [Full Text] [Related]

  • 9. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM, El-Awady RA, Abdel Alim MA, Abdel Wahab AH.
    Cell Biochem Biophys; 2009 Sep 16; 55(2):95-105. PubMed ID: 19593673
    [Abstract] [Full Text] [Related]

  • 10. Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.
    Vijayaraghavalu S, Dermawan JK, Cheriyath V, Labhasetwar V.
    Mol Pharm; 2013 Jan 07; 10(1):337-52. PubMed ID: 23215027
    [Abstract] [Full Text] [Related]

  • 11. Algerian propolis: between protection of normal cells and potentialisation of the anticancer effects of doxorubicin against breast cancer cells via P-glycoprotein inhibition and cell cycle arrest in the S phase.
    Rouibah H, Kebsa W, Lahouel M, Zihlif M, Ahram M, Aburmaileh B, Mansour Al Shhab MA, Al-Ameer HJ, Mustafa E.
    J Physiol Pharmacol; 2021 Apr 07; 72(2):. PubMed ID: 34374660
    [Abstract] [Full Text] [Related]

  • 12. PEMF Potentiates Doxorubicin-induced Late G2 Arrest in MDA-MB-231 Breast Cancer Cells.
    Woo SH, Jung BC, Kim JY, Lee YH, Kim YS.
    Anticancer Res; 2024 Jul 07; 44(7):2837-2846. PubMed ID: 38925852
    [Abstract] [Full Text] [Related]

  • 13. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
    Chen JM, Bai JY, Yang KX.
    IUBMB Life; 2018 Jun 07; 70(6):491-500. PubMed ID: 29637742
    [Abstract] [Full Text] [Related]

  • 14. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W, Lahouel M, Rouibah H, Zihlif M, Ahram M, Abu-Irmaileh B, Mustafa E, Al-Ameer HJ, Al Shhab M.
    Anticancer Agents Med Chem; 2018 Jun 07; 18(9):1330-1337. PubMed ID: 30088453
    [Abstract] [Full Text] [Related]

  • 15. Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells.
    Ogata R, Kishino E, Saitoh W, Koike Y, Kurebayashi J.
    Breast Cancer; 2021 Jan 07; 28(1):206-215. PubMed ID: 32860163
    [Abstract] [Full Text] [Related]

  • 16. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells.
    Arafa el-SA, Zhu Q, Shah ZI, Wani G, Barakat BM, Racoma I, El-Mahdy MA, Wani AA.
    Mutat Res; 2011 Jan 10; 706(1-2):28-35. PubMed ID: 21040738
    [Abstract] [Full Text] [Related]

  • 17. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
    Ku JM, Kim SR, Hong SH, Choi HS, Seo HS, Shin YC, Ko SG.
    Mol Cell Biochem; 2015 Nov 10; 409(1-2):33-43. PubMed ID: 26169986
    [Abstract] [Full Text] [Related]

  • 18. Saikosaponin D potentiates the antineoplastic effects of doxorubicin in drug-resistant breast cancer through perturbing NQO1-mediated intracellular redox balance.
    Luo F, Yang J, Yang X, Mi J, Ye T, Li G, Xie Y.
    Phytomedicine; 2024 Oct 10; 133():155945. PubMed ID: 39146878
    [Abstract] [Full Text] [Related]

  • 19. Morin overcomes doxorubicin resistance in human breast cancer by inducing DNA damage and modulating the LKB1/AMPK/mTORC1 signaling pathway.
    Maharjan S, Lee MG, Lee KS, Nam KS.
    Biofactors; 2024 Aug 08. PubMed ID: 39114963
    [Abstract] [Full Text] [Related]

  • 20. Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways.
    Wei T, Xiaojun X, Peilong C.
    Biomed Pharmacother; 2020 Jan 08; 121():109139. PubMed ID: 31707337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.